ライフサイエンスコーパス: lactoferrin

1 release of antibacterial myeloperoxidase and lactoferrin.

2 ey, Lactalbumin, Lactoferrin, or pair-fed to lactoferrin.

3 tract iron from hemoglobin, transferrin, and lactoferrin.

4 secretion of bactericidal concentrations of lactoferrin.

5 with the ferric iron within transferrin and lactoferrin.

6 uch as Magainin II amide, hNP1-3, LL-37, and lactoferrin.

7 partially iron-saturated transferrin but not lactoferrin.

8 the highly cationic lactoferricin moiety of lactoferrin.

9 epresent major associations between PspA and lactoferrin.

10 identified the proteins as fibronectin-1 and lactoferrin.

11 eficial iron-scavenging molecules, including lactoferrin.

12 -treated, and 10 subjects received untreated lactoferrin.

13 properties and its propensity to bind human lactoferrin.

14 human serum transferrin, ovotransferrin, and lactoferrin.

15 Antibody to PspA enhanced killing by lactoferrin.

16 gatively regulated the myeloid-specific gene lactoferrin.

17 y be the cause of the differential action of lactoferrin.

18 mediated by the highly charged N terminus of lactoferrin.

19 e Ala-Leu-Leu-Cys-, which occurs in salivary lactoferrin.

20 pretreatment of Aa cells with iron-saturated lactoferrin.

21 eroxide production stimulated by immobilized lactoferrin.

22 eat potential for functional foods providing lactoferrin.

23 unique mechanism of action for lysozyme and lactoferrin.

24 elations with levels of the glandular marker lactoferrin.

25 ody iron absorption between the groups given lactoferrin (20.4 +/- 15.3%; n = 20) or ferrous sulfate

26 Human lactoferrin, a component of the innate immune system, ki

27 Lactoferrin, a glycoprotein present in human milk, inhib

28 ors enhances megalin-mediated uptake of 125I-lactoferrin, a megalin ligand.

29 s of diverse lineages synthesize and secrete lactoferrin, a pleiotropic glycoprotein with known antii

30 the human small intestine has receptors for lactoferrin, a role for it in iron absorption has been s

31 Finally, interleukin-27 or lactoferrin administration results in reduced edema, enh

32 y was to assess the utility of ascitic fluid lactoferrin (AFLAC) for the diagnosis of SBP and to iden

33 esents scientific and clinical evidence that lactoferrin alleviates or prevents this life-threatening

34 cropeptide, immunoglobulin, lactoperoxidase, lactoferrin, alpha-lactalbumin and beta-lactoglobulin fr

35 n injected into the mouse peritoneal cavity, lactoferrin also caused a marked recruitment of neutroph

36 d fungal growth and were found to be rich in lactoferrin, an abundant PMN secondary granule protein.

37 e epithelial ERalpha was necessary to induce lactoferrin, an E(2)-regulated secretory protein selecti

38 In contrast, lactoferrin, an effector molecule of innate immune mecha

39 Lactoferrin, an important part of the innate host defens

40 ere enriched for the specific granule marker lactoferrin and 82% with the azurophil granule marker el

41 some proteins from human milk but did affect lactoferrin and alpha-lactalbumin proteolysis and emulsi

42 tory bowel disease had measurements of fecal lactoferrin and alpha1-antitrypsin and underwent pouch e

43 hils that was essential to the production of lactoferrin and bacterial killing.

44 markers of inflammation, specifically stool lactoferrin and calprotectin as well as small intestine

45 es identified so far, autoantibodies against lactoferrin and carbonic anhydrase II are most frequentl

46 trophil-specific granule proteins, including lactoferrin and collagenase.

47 deficient local production of antimicrobial lactoferrin and deficient functioning of the bitter tast

48 es is revealed by elevated plasma and tissue lactoferrin and ET-1 levels in patients with TNBC compar

49 for the use of iron bound by transferrin and lactoferrin and examined the importance of the Ybt syste

50 l that, in contrast to family members (human lactoferrin and hen ovotransferrin), both lobes are almo

51 showed a stronger positive correlation with lactoferrin and IL-1ra and a stronger negative correlati

52 ctoferrin (ALF) is the iron-depleted form of lactoferrin and is bactericidal against pneumococci and

53 gradation of antimicrobial proteins, such as lactoferrin and members of the beta-defensin family.

54 Markers of inflammation, including fecal lactoferrin and mucosal cytokines, have been reported as

55 he leukocyte transcriptome by downregulating lactoferrin and other genes important in the pathogenesi

56 ether iron binding proteins; apotransferrin, lactoferrin and ovotransferrin; could prevent the hydrox

57 Concentrations of lactoferrin and secretory leukocyte protease inhibitor (

58 All three sLRPs also bound lactoferrin and thrombin-protease nexin 1 complexes.

59 n of detailed site-specific glycosylation of lactoferrin and transferrin following gel separation and

60 n use both bovine and human versions of both lactoferrin and transferrin, contrary to previous report

61 s phenomenon was mediated by transferrin and lactoferrin and was influenced by the iron-saturation st

62 Bovine serum albumin, lactoferrin, and alpha-casein (S1 and S2 forms, as was r

63 gen species, as well as the release of NETs, lactoferrin, and chemotactic stimuli.

64 toglobin, transferrin, transferrin receptor, lactoferrin, and ferritin in the bronchoalveolar lavage

65 ncreased expression of transferrin receptor, lactoferrin, and ferritin in the lower respiratory tract

66 day contained adequate amounts of lacritin, lactoferrin, and lipocalin for use in lacritin secretion

67 The lactoferrin appears to coat the peptide fibril surface t

68 Levels of lactoferrin are consistently elevated in inflammatory di

69 Target proteins fixed on the EIG (protein G, lactoferrin) are detected using antibody probes with sig

70 Together, our results identify lactoferrin as an antiinflammatory component of the apop

71 -binding proteins, including transferrin and lactoferrin, as iron sources.

72 eactive oxygen species, myeloperoxidase, and lactoferrin, as well as the inflammatory chemokine IL-8

73 Purified iron-poor lactoferrin at concentrations occurring in PMN supernata

74 etry further revealed that rTp34 bound human lactoferrin at high (submicromolar) affinity.

75 In this study, glycoproteins such as, bovine lactoferrin (b-LF) for N-glycosylation and kappa casein

76 In vivo, the intravenous administration of lactoferrin-bearing DAB dendriplex resulted in a signifi

77 Lactoferrin-bearing generation 3 polypropylenimine dendr

78 rain barrier, we propose to investigate if a lactoferrin-bearing generation 3-diaminobutyric polyprop

79 and decreased adiposity, with the effects of lactoferrin being partly independent of caloric intake.

80 There is an increase in the levels of lactoferrin, beta(2)-microglobulin, sodium, lysozyme C,

81 of syphilis, was previously reported to have lactoferrin binding properties.

82 The crystal structure of a complex of the lactoferrin-binding domain of PspA with the N-lobe of hu

83 the best 3 peptides, peptide A, derived from lactoferrin-binding protein A, showed superior activity

84 The bovine milk glycoprotein bovine lactoferrin (bLF) has a variety of biological activities

85 Lactoferrin blocked EPEC-mediated actin polymerization i

86 On the basis that lactoferrin can effectively reach the brain by using spe

87 Fecal lactoferrin can serve as a sensitive and noninvasive ini

88 apolactoferrin, the iron-free form of human lactoferrin, can kill many species of bacteria, includin

89 The genes encoding lysozyme, lactoferrin, cathelicidin antimicrobial peptide (hCAP18/

90 hil granules, including neutrophil elastase, lactoferrin, cathepsin G, proteinase 3, and myeloperoxid

91 bumin produced transient hypophagia, whereas lactoferrin caused prolonged hypophagia; the hypophagia

92 In additional work, we found that lactoferrin cleaves IgA1 protease at an arginine-rich re

93 infants should receive colostrum, a natural lactoferrin concentrate, immediately after birth and, id

94 Samples with SBP had a significantly higher lactoferrin concentration (median, 3744 ng/mL; 25th-75th

95 examined for PMN count, bedside culture, and lactoferrin concentration.

96 ory condition had significantly higher fecal lactoferrin concentrations (median, 176.0 microg/mL, int

97 The inhibitory effect of various lactoferrin concentrations on the growth of C. albicans

98 -Cys-blocked the interaction between MG2 and lactoferrin, confirming the specificity of the interacti

99 antly greater bactericidal activity than did lactoferrin containing Arg.

100 cus mutans and Streptococcus mitis, however, lactoferrin containing Lys at position 29 exhibited sign

101 om subjects with this SNP, recombinant human lactoferrin containing this SNP, or an 11-mer peptide de

102 These results suggest that lactoferrin contributes to the activation of both the in

103 At a cutoff level of 7 microg/mL, fecal lactoferrin could distinguish patients with irritable po

104 f the type III secretory system implies that lactoferrin could provide broad cross protection against

105 Interestingly, lactalbumin and lactoferrin decreased hepatic lipidosis partly through d

106 Lactalbumin and lactoferrin decreased plasma leptin and insulin, and lac

107 To determine the mechanism by which lactoferrin decreases invasiveness of Shigella organisms

108 therapeutic ET-1 receptor-antagonist blocked lactoferrin-dependent motility and invasiveness of breas

109 polactoferrin but did not block killing by a lactoferrin-derived peptide.

110 Lactoferrin did not have any effect on the ascorbate ind

111 We discovered that lactoferrin directly stimulates the transcription of end

112 peptide derived from the N terminus of human lactoferrin, displays diverse modulatory activities on m

113 Lactoferrin does not bind to insulin or lysozyme fibrils

114 Furthermore, although full-length lactoferrin does not by itself form amyloid fibrils, the

115 Lactoferrin does not directly degrade previously release

116 equal proportions to the plasma membrane and lactoferrin-enriched fractions, consistent with FPRL1 si

117 lasma membrane with a minor component in the lactoferrin-enriched intracellular fractions, consistent

118 nd eukaryotic binding proteins (transferrin, lactoferrin, ferritin, haemoglobin).

119 e have evaluated the potential of camel milk lactoferrin for its ability to inhibit the proliferation

120 Blotting experiments confirmed that MG2 and lactoferrin form a heterotypic complex in vitro and in v

121 factor (ARF) and Rho, stimulating release of lactoferrin from specific granules of permeabilized PMNs

122 In vitro data indicate that lactoferrin from whole saliva derived from subjects with

123 Lactoferrin functioned as an LRP1 signaling antagonist,

124 lpyridinium were also partially protected by lactoferrin, further supporting the view that mitochondr

125 However, molecular mechanisms of how the lactoferrin gene is regulated in the mammary gland in re

126 Sequence analysis of the isolated lactoferrin gene revealed that the promoter region conta

127 An 8.2 kilobase (kb) fragment of the bovine lactoferrin gene, containing 4.4 kb of 5' flanking regio

128 terized the 5' flanking region of the bovine lactoferrin gene.

129 cleotide polymorphism in exon 1 of the human lactoferrin gene.

130 rest among neonatal caregivers as to whether lactoferrin given enterally may reduce the incidence of

131 linical studies in neonatal rats showed that lactoferrin given orally before enteral infection with p

132 They also express gelatinase and lactoferrin granule proteins.

133 neutrophil elastase) and specific (CD66b and lactoferrin) granule markers.

134 ow-birth weight preterm infants given bovine lactoferrin had a significant reduction in late-onset se

135 Lactoferrin has previously been identified in amyloid de

136 In recent work, we observed that lactoferrin has proteolytic activity and attenuates the

137 actoferrin alfa, a recombinant form of human lactoferrin, has similar properties and plays an importa

138 Single-nucleotide polymorphisms (SNPs) in lactoferrin have been shown to be present in individuals

139 Fecal markers such as calprotectin and lactoferrin have been studied for their ability to ident

140 certain antimicrobial proteins, most notably lactoferrin, have been found in sinus secretions, wherea

141 Human lactoferrin (hLf) has been shown to interact with cells

142 Soluble lactoferrin, however, did not activate the eosinophils a

143 Pro-Ile) and a casein (CasH), whey (WPH) and lactoferrin hydrolysate (LFH) generated with gastrointes

144 Lactoferrin impairs ability of Shigella flexneri serotyp

145 Dietary lactalbumin and lactoferrin improved energy balance and metabolism, and

146 Whey, lactalbumin and lactoferrin improved glucose clearance partly through di

147 The concentration of lactoferrin in bovine milk is dramatically increased in

148 enterobactin, ferrichrome, transferrin, and lactoferrin in E. coli.

149 (2+) cryogel system was also able to capture lactoferrin in high purity.

150 Lactoferrin in human milk removes or cleaves Hap and ano

151 ing the microfluidic WB assay, assessment of lactoferrin in human tear fluid is demonstrated with a g

152 l, our data suggest that the accumulation of lactoferrin in PD brains might be evidence of an attempt

153 nes to obtain iron from both transferrin and lactoferrin in the absence of siderophore.

154 extend previous studies of the importance of lactoferrin in the innate immune defense against bacteri

155 ementation, recombinant human protein C, and lactoferrin in the prevention and treatment of neonatal

156 ects homozygous for this lysine (K) SNP have lactoferrin in their saliva that kills mutans streptococ

157 dalities, such as MRI, and biomarkers (fecal lactoferrin) in pediatric inflammatory bowel disease.

158 Furthermore, we found that lactoferrin increases migration and invasiveness of both

159 Lactoferrin induced degradation of invasion plasmid anti

160 receptor antagonist to completely block the lactoferrin-induced motility and invasiveness of the TNB

161 ondary forms of antimicrobial defense, e.g., lactoferrin, ineffective in preventing biofilm formation

162 Lactoferrin inhibits bacterial growth by sequestering es

163 relevance of these catecholamine-transferrin/lactoferrin interactions to the infectious disease proce

164 we found that the iron binding capability of lactoferrin intervened in DA cell rescue only when neuro

165 Lactoferrin is a glycoprotein present in most human muco

166 Lactoferrin is a glycoprotein with anti-infective and an

167 Lactoferrin is a major protein component of human milk,

168 Lactoferrin is a member of the lactotransferrin family o

169 Lactoferrin is a protein that is present in cheese whey

170 The binding of lactoferrin is a selective interaction with the NAGDVAFV

171 Based on our results, we conclude that lactoferrin is a serine protease capable of cleaving arg

172 The iron-binding protein lactoferrin is a ubiquitous and abundant constituent of

173 Lactoferrin is an 80-kDa iron-binding protein present at

174 Lactoferrin is an important component of innate immunity

175 Lactoferrin is bacteriostatic in low iron media and, in

176 Lactoferrin is bound to the pneumococcal surface by pneu

177 Thus, iron provided by dietary lactoferrin is likely to be well utilized in human adult

178 Lactoferrin is one of a number of multifunctional protei

179 ed proteomic analysis of CA/PC revealed that lactoferrin is the predominant protein component, a resu

180 ave shown that the iron-binding glycoprotein lactoferrin is upregulated in dopamine (DA) neurons resi

181 11-amino-acid peptide from the N terminus of lactoferrin, is bactericidal for Streptococcus pneumonia

182 ositions in ovotransferrin (Q-K-L) and human lactoferrin (K-N-N) as well as a triad with an interchan

183 In this study, we used lactoferrin knockout (LFKO) mice to directly address the

184 Lactoferrin (Lac), a glycoprotein present in milk, has b

185 ived proteins, including transferrin (TbpA), lactoferrin (LbpA), and hemoglobin (HpuB), in addition t

186 If fecal lactoferrin levels are high, pouch endoscopy with biopsy

187 If fecal lactoferrin levels are low (<7 microg/mL), IPS can be di

188 Differences in fecal lactoferrin levels suggest variable presence or severity

189 Lactoferrin levels were higher in the GDH-positive/toxin

190 In the lung, Fe is also bound to lactoferrin (LF) and low-molecular-weight chelates.

191 Bovine lactoperoxidase (LPO) and lactoferrin (LF) are suitable proteins to be loaded or a

192 The potential of bovine lactoferrin (LF) as a source of antihypertensive peptide

193 In this study, we discovered that lactoferrin (Lf) efficiently downregulates levels of ER-

194 s issue, we focused on the expression of the lactoferrin (LF) gene.

195 Lactoferrin (Lf) has considerable potential as a functio

196 nnate defense mechanisms in the oral cavity, lactoferrin (LF) is a vital antimicrobial that can modif

197 Although lactoferrin (Lf) is abundant on mucosa and in purulent e

198 Lactoferrin (LF) is an iron-binding protein found in mil

199 Lactoferrin (Lf) samples with ca. 25%, 50%, 75%, 85% and

200 ins, together with human holo- and apoTF and lactoferrin (LF) were assessed as inhibitors of all cata

201 operties of a fluorescently labeled protein, lactoferrin (Lf), and its association with heparin and h

202 nists, receptor-associated protein (RAP) and lactoferrin (LF), and LRP1-specific antibody had the ent

203 estrogen-inducible uterine secretory protein lactoferrin (LF), and reduced expression of SV secretory

204 Three forms of bovine lactoferrin (Lf), apo-, native- and holo- with 0.9%, 12.

205 ary and tertiary granule mRNAs is absent for lactoferrin (LF), neutrophil gelatinase (NG), murine cat

206 Lactoferrin (Lf), the main iron-binding protein of milk,

207 tely 0.35 mum, 20 wt.%) with a suspension of lactoferrin (LF)-coated lipid droplets (zeta=+32 mV, d(4

208 se were used as model moieties reacting with lactoferrin (LF).

209 Lactoferrins (LFs) at iron-saturation 8 (native) and 100

210 acteria by release of Tamm-Horsfall protein, lactoferrin, lipocalin, and constitutive and inducible b

211 teins IIb/IIIa (ITGA2B/3), lipocalin (LCN2), lactoferrin (LTF), and the thrombopoetin receptor (MPL),

212 line downregulated C/EBP-epsilon protein and lactoferrin (Ltf), cathelicidin antimicrobial protein (C

213 irmed the presence of proline-rich proteins, lactoferrin, lysozyme, and carbonic anhydrase II by prob

214 lase, carbonic anhydrase II, sIgA, IgG, IgM, lactoferrin, lysozyme, proline-rich proteins, statherin,

215 h protease inhibitors further suggested that lactoferrin may belong to a serine protease family.

216 In addition, we speculate that lactoferrin may cleave arginine-rich sequences in a vari

217 The high levels of lactoferrin may have a role in the prevention of microbi

218 Tp34 to bind zinc and the iron-sequestering lactoferrin may relate overall to the biology of T. pall

219 ted against S. pneumoniae that appears to be lactoferrin mediated.

220 The mechanism of this inhibition was lactoferrin-mediated degradation of secreted proteins ne

221 so be modulated by human transferrin- and/or lactoferrin-mediated iron chelation.

222 These results suggest that interleukin-27/lactoferrin-mediated modulations of neutrophil function

223 r ferric iron transport from transferrin and lactoferrin, might also contribute to the utilization of

224 in cell counts when milk contained 3.0 mg of lactoferrin/ml and markedly reduced the likelihood of fa

225 Human lactoferrin of either recombinant or natural origin prov

226 operoxidase, beta-glucuronidase) and 40-80% (lactoferrin) of maximal when compared with formylmethion

227 To determine the effect of lactoferrin on the initial host cell attachment step tha

228 n, bovine serum albumin, beta-galactosidase, lactoferrin) on the EIG with initial capture efficiencie

229 ining whey, or its fractions lactalbumin and lactoferrin, on energy balance and metabolism.

230 in there is no evidence for the formation of lactoferrin-only fibrils.

231 upplemented in randomized order with 59Fe as lactoferrin or as ferrous sulfate.

232 elated in subjects when they received either lactoferrin or ferrous sulfate, which suggested that iro

233 creased fungal growth, whereas saturation of lactoferrin or PMN supernatants with iron, or testing in

234 ing inflammatory markers such as leukocytes, lactoferrin, or calprotectin, or positive stool culture

235 socaloric diets: Control, Whey, Lactalbumin, Lactoferrin, or pair-fed to lactoferrin.

236 f these proteins, such as alpha-lactalbumin, lactoferrin, osteopontin, and milk fat globule membrane

237 Pasteurization enhanced the proteolysis of lactoferrin (P < 0.01) and reduced that of alpha-lactalb

238 globulin (P = 0.010), casein (P = 0.047) and lactoferrin (P = 0.030) during treatment than those who

239 A synthetic lactoferrin peptide containing the motif Ala-Leu-Leu-Cys

240 testing [Hemoccult], fecal leukocytes, fecal lactoferrin, plasma C-reactive protein), and the numbers

241 Lactoferrin present in human milk can inhibit growth of

242 insically labeled purified recombinant human lactoferrin produced in rice and to compare it with the

243 Notably, lactoferrin produced sustained weight and fat loss, and

244 en together, our findings suggested that the lactoferrin promoter responds to infection via the NF-ka

245 e present study we explored the mechanism of lactoferrin protease activity and discovered that mutati

246 ondria may represent a downstream target for lactoferrin protective actions.

247 We determined fecal interleukin 8 (IL-8) and lactoferrin protein concentrations by enzyme immunoassay

248 erin, and Ppib and the fourth binds to human Lactoferrin protein.

249 xcess of unlabeled HLE, CG, myeloperoxidase, lactoferrin, proteinase 3, phenylmethylsulfonyl fluoride

250 and this bacterium uses both transferrin and lactoferrin receptors to fulfill the essential iron requ

251 r cut between amino acids 78 and 79 of human lactoferrin, removing the N-terminal end of the molecule

252 The lipid A-binding N-terminal portion of lactoferrin (residues 1-33) induces release of invasion

253 ding domain of PspA with the N-lobe of human lactoferrin reveals direct and specific interactions bet

254 Targets of desialylation included human lactoferrin, secretory component, and IgA2 that were sho

255 We further demonstrated that lactoferrin selectively inhibited migration of granulocy

256 this paper a highly amyloidogenic region of lactoferrin (sequence of NAGDVAFV).

257 These results demonstrate that PMN lactoferrin sequestration of iron is important for host

258 , including whole blood, plasma, hemoglobin, lactoferrin, serum IgG, soil extracts and humic acid, as

259 ated and sialylated glycopeptides from human lactoferrin served as positive controls, and high-mannos

260 Here, we review data showing a lactoferrin SNP in amino acid position 29 in the antimic

261 In addition, the Lys-containing lactoferrin stimulated bovine tracheal epithelial cells

262 degree than did that with apotransferrin and lactoferrin, suggesting additional effects of these ferr

263 -1, and late differentiation markers such as lactoferrin, suggesting that this kinase induced termina

264 recorded, and mRNA expression levels of Ltf (lactoferrin), Svs4, and androgen receptor (Ar) were asse

265 dy, we show the ability of recombinant human lactoferrin (talactoferrin alfa (TLF)) to chemoattract m

266 These included lysozyme, lactoferrin, tear lipocalin, and lacritin.

267 d position 29 in the antimicrobial region of lactoferrin that acts against caries associated bacteria

268 Ten subjects received lactoferrin that had been heat-treated, and 10 subjects

269 eficial molecules, including iron-scavenging lactoferrin that may limit hematoma/iron-mediated brain

270 osition 29 in the N-terminal region of human lactoferrin that results from a single nucleotide polymo

271 e to be a novel antiinflammatory property of lactoferrin: the ability to function as a negative regul

272 histochemistry (IHC) suggested the source of lactoferrin to be prostate-infiltrating neutrophils as w

273 attribute this antiinflammatory function of lactoferrin to its effects on granulocyte signaling path

274 phils via, at least partly, the induction of lactoferrin to present a potential therapy for ICH.

275 letion, regulatory burdens required to bring lactoferrin to the bedside may limit its availability.

276 ork, we demonstrated that the conjugation of lactoferrin to the dendrimer led to an enhanced DNA upta

277 macrogobulin, type IV collagen, fibronectin, lactoferrin, transferrin, and immunoglobulins.

278 Although multicentered trials of lactoferrin use in preterm infants are near completion,

279 three porin-independent phenotypes, namely, lactoferrin utilization, beta-lactamase production, and

280 Our findings suggest that these two lactoferrin variants are functionally different and that

281 The two lactoferrin variants exhibited nearly identical iron-bin

282 We expressed cDNAs encoding both lactoferrin variants in insect cells and purified the tw

283 olamines to obtain iron from transferrin and lactoferrin via uptake pathways involving the BfrA, BfrD

284 Neuroprotection by lactoferrin was attributable to its binding to heparan s

285 The efficacy of lactoferrin was comparable to that of glial cell line-de

286 Quantitative fecal lactoferrin was measured in 112 patients tested for toxi

287 = 10) and untreated (16.2 +/- 4.4%; n = 10) lactoferrin was not significant.

288 The proteolytic effect of lactoferrin was prevented by serine protease inhibitors.

289 To this end, a potent AMP derived from human lactoferrin was synthesized and covalently immobilized o

290 ary and tertiary granule products, including lactoferrin, was normal.

291 e on simulated data for adenylate kinase and lactoferrin, we show how cryo-EM data for two different

292 Iron is equally well absorbed from lactoferrin (whether heat-treated or untreated) and ferr

293 t for the chromatographic process to capture lactoferrin whey.

294 Here, we examine two proteins, lysozyme and lactoferrin, which are observed in the organic matrix of

295 recombinant form of the human glycoprotein, lactoferrin, which has been shown to have a wide range o

296 binds the iron-free forms of transferrin and lactoferrin, which limits its ability to extract iron fr

297 c-iron-binding proteins transferrin (Tf) and lactoferrin, which then enables bacterial acquisition of

298 -stabilized dimer and that rTp34 bound human lactoferrin with a stoichiometry of 2:1.

299 hesis and suggests that a genetic variant in lactoferrin with K in position 29 when found in saliva a

300 DNA methyltransferase (MGMT), SNAP-tag, and lactoferrin, with four different probes.